Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics

Cell Proliferation

Volumn 33, Issue 1, 2000, Pages 1-18

  Roncucci, L ^a   Pedroni, M ^a   Vaccina, F ^a   Benatti, P ^a   Marzona, L ^a   De Pol, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; METHYLENE BLUE; PROTEIN P53;

ANIMAL CELL; CARCINOGENESIS; CELL KINETICS; CELL STRUCTURE; COLON CANCER; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; HISTOLOGY; HUMAN; HUMAN CELL; NONHUMAN; RAT; REVIEW; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; CELL DIVISION; COLORECTAL NEOPLASMS; GENES, APC; HUMANS; INTESTINAL MUCOSA; KINETICS; MICROSCOPY, ELECTRON, SCANNING; PRECANCEROUS CONDITIONS;

ANIMALIA; RODENTIA;

EID: 0034100967     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2000.00159.x     Document Type: Review

References (165)

1. Aaltonen LA, Peltomäki P, Leach FS et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260, 812.
2. Anti M, Marra G, Armelao F et al. (1993) Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 34, 525.
3. Arai T, Kino I. (1995) Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J. Pathol. 176, 37.
4. Augenlicht LH, Richards C, Corner G, Pretlow TP. (1996) Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 12, 1767.
5. Barnes CJ, Cameron IL, Hardman WE, Lee M. (1998) Non-steroid anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br. J. Cancer 77, 573.
6. Barrow BJ, O'Riordan MA, Stellato TA, Calkins BM, Pretlow TP. (1990) Enzyme-altered foci in colons of carcinogen-treated rats. Cancer Res. 50, 1911.
7. Bedi A, Pasricha PJ, Akhtar AJ et al. (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55, 1811.
8. Bertoni G, Sassatelli R, Nigrisoli E, Tansini P, Roncucci L, Ponz De Leon M, Bedogni G. (1995) First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies. Gastroenterology 109, 374.
9. Biasco G, Lipkin M, Minarini A, Higgins P, Miglioli M, Barbara L. (1984) Proliferative and antigenic properties of rectal cells in patients with chronic ulcerative colitis. Cancer Res. 44, 5450.
10. Bird RP. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37, 147.
11. Bird RP, McLellan EA, Bruce WR. (1989) Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv. 8, 189.
12. Bjerknes M, Cheng H, Hay K, Gallinger S. (1997) APC mutation and the crypt cycle in murine and human intestine. Am J. Pathol. 150, 833.
13. Bodmer WF, Bailey CJ, Bodmer J et al. (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328, 614.
14. Bos JL. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682.
15. Bouzourene H, Chaubert P, Seelentag W, Bosman FT, Saraga E. (1999) Aberrant crypt foci in patients with neoplastic and non-neoplastic colonic disease. Hum. Pathol. 30, 66.
16. Browne SJ, Williams AC, Hague A, Butt AJ, Paraskeva C. (1994) Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int. J. Cancer 59, 56.
17. Bruce WR, Archer MC, Corpet DE et al. (1993) Diet, aberrant crypt foci and colorectal cancer. Mutat. Res. 290, 111.
18. Buchi KN, Moore JG, Hrushesky WJM, Sothern RB, Rubin NH (1991) Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 101, 410.
19. Caderni G, Bianchini F, Mancina A, Spagnesi MT, Dolara P. (1991) Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2-dimethylhydrazine. Cancer Res. 51, 3721.
20. Caderni G, Giannini A, Lancioni L, Luceri C, Biggeri A, Dolara P. (1995) Characterization of aberrant crypt foci in carcinogen-treated rats. Association with intestinal carcinogencsis. Br. J. Cancer 71, 763.
21. Caderni G, Luceri C, Lancioni L, Tessitorf L, Dolara P. (1998) Slow-release pellets of sodium butyrate increase apoptosis in the colon of rats treated with azoxymethane, without affecting aberrant crypt foci and colonic proliferation. Nutr. Cancer 30, 175.
22. Cats A, Dullaart RPF, Kleibeuker JH et al. (1996) Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res. 56, 523.
23. Chang WWL. (1984) Histogenesis of colon cancer in experimental animals. Scand. J. Gastroenterol. 19 (Suppl. 104), 27.
24. Cheng H, Bjerknes M, Amar J, Gardiner G. (1986) Crypt production in normal and diseased human colonic epithelium. Anat. Rec. 319, 44.
25. 3. Gastroenterology 41, 122.
26. Corpet DE, Stamp D, Medline A, Minkin S, Archer MC, Bruce WR. (1990) Promotion of colonics microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer Res. 50, 6955.
27. Corpet DE, Tachė S, Peiffer G. (1997) Colon tumor promotion: is a selection process? Effect of cholate, phytate, and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts. Cancer Lett. 114, 135.
28. Davies MJ, Rumsby PC. (1998) Long.term analysis of colonic aberrant crypt formation after treatment of Sprague Dawley rats with azoxymethane. Teratog. Carcinog. Mutagen. 18, 183.
29. De Filippo C, Caderni G, Bazzigalupo M et al. (1998) Mutations of the Ape gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br. J. Cancer 77, 2148.
30. Deschner EE. (1974) Experimentally induced cancer of the colon. Cancer 34, 824.
31. Deschner EE. (1980) Cell proliferation as a biological marker in human colorectal neoplasia. In: Winawer S, Schottenfeld D, Sherlock P, eds. Colorectal Cancer: Prevention, Epidemiology, and Screening. New York: Raven Press.
32. 3 thymidine incorporation in mucosa of multiple polyposis. J. Clin. Invest. 42, 1922.
33. Deschner EE, Raicht RF. (1981) Kinetic and morphologic alterations in the colon of a patient with multiple polyposis. Cancer 47, 2440.
34. Di Gregorio C, Losi L, Fante R et al. (1997) Histology of aberrant crypt foci in the human colon. Histopathology 30, 328.
35. Dolara P, Caderni G, Lancioni L et al. (1997) Aberrant crypt foci in human colon carcinogenesis. Cancer Detect. Prev. 21, 135.
36. El-Deiry WS, Tokino T, Velculescu VE et al. (1993) WAFI, a potent mediator of p53 tumor suppression. Cell 75, 817.
37. Endo Y, Sugimura H, Kino I. (1995) Monoclonality of normal human colonic crypts. Pathol. Int. 45, 602.
38. Farber E, Rubin H. (1991) Cellular adaptation in the origin and development of cancer. Cancer Res. 51, 2751.
39. Fearon ER, Vogelstein B. (1990) A genetic model of colorectal carcinogenesis. Cell 61, 759.
40. Feng Y, Fretland AJ, Rustan TD, Jiang W, Becker WK, Hein DW. (1997) Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2-dimethyl-4-aminobiphenyl. Toxicol. Appl. Pharmacol. 147, 56.
41. Fujimitsu Y, Nakanishi H, Inada K et al. (1996) Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn. J. Cancer Res. 87, 1199.
42. Garewai H, Bernstein H, Bernstein C, Sampliner R, Payne C. (1996) Reduced bile acid-induced apoptosis in 'normal' colorectal mucosa: a potential biological marker for cancer risk. Cancer Res. 56, 1480.
43. Griffiths DFR, Davies SJ, Williams D, Williams GT, Williams ED. (1988) Demonstration of somatic mutations and colonic crypt clonality by X-linked enzyme histochemistry. Nature 333, 461.
44. Groden J, Thliveris A, Samowitz W et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589.
45. Gumbiner BM. (1996) Cell adhesion, the molecular basis of tissue architecture and morphogenesis. Cell 84, 345.
46. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P. (1988) C-jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinities. Cell 55, 917.
47. Hardman WE, Cameron IL, Heitman DW, Contreras E. (1991) Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence. Cancer Res. 51, 6388.
48. He TC, Sparks AB, Rago C et al. (1998) Identification of c.myc as a target of the APC pathway. Science 28, 1509.
49. Heinen CD, Shivapurkar N, Tang Z, Groden J, Alabaster O. (1996) Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 56, 5339.
50. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. (1990) Bcl-2 is.an inner mitocondrial membrane protein that blocks programmed cell death. Nature 348, 334.
51. Ionov YM, Peinado A, Malkhosyan S, Shibata D, Perucho M. (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558.
52. Jen J, Powell SM, Papadopoulos N et al. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54, 5523.
53. Jenab M, Thompson LU. (1998) The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19, 1087.
54. Kennedy MFG, Tutton PJM, Barkla DH. (1985) Comparison of the variation in cell proliferation in normal and neoplastic colonic epithelial cells. Cancer Lett. 28, 169.
55. Kerr JFR, Wyllie AH, Currie AR. (1972) Apoptosis, a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239.
56. Kinzler KW, Nilbert MC, Su L-K et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253, 661.
57. Kinzler KW, Vogelstein B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159.
58. Kleibeuker JH, Cats A, Zwart N et al. (1995) Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides. J. Natl. Cancer Inst. 87, 452.
59. Konstantakos AK, Siu I-M, Pretlow TG, Stellato TA, Pretlow TP. (1996) Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 111, 772.
60. Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR. (1997) Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr. Cancer 29, 69.
61. Kurimasa A, Puyang H, Dong L-J et al. (1999) Catalytic subunit of DNA-dependent protein kinase. Impact on lymphocyte development and tumorigenesis. Proc. Natl. Acad. Sci. USA 96, 1403.
62. Leach FS, Nicolaides NC, Papadopoulos N et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215.
63. Lehy T, Abitbol J-L, Mignon M. (1984) Influence de la préparation rectale par lavement sur la prolifération cellulaire dans la muqueuse rectale normale de l'homme. Gastroenterol. Clin. Biol. 8, 216.
64. Levine DS, Haggitt RC. (1989) Normal histology of the colon. Am. J. Surg. Pathol. 13, 966.
65. Lipkin M. (1988) Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res. 48, 235.
66. Lipkin M, Blattner WE, Fraumeni JF Jr, Linch HT, Deschner E, Winawer S. (1983) Tritiated thymidine (Φp,Φh) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res. 43, 1899.
67. Lipkin M, Quastler H. (1962) Cell population kinetics in the colon of the mouse. J. Clin. Invest. 41, 141.
68. Lipkin M, Sherlock P, Bell B. (1963) Cell population kinetics in the gastrointestinal tract of man. II. Cell renewal in stomach, ileum, colon, and rectum. Gastroenterology 45, 721.
69. Losi L, Roncucci L, Di Gregorio C, Ponz de Leon M, Benhattar J. (1996) K-ras and p53 mutations in human colorectal aberrant crypt foci. J. Pathol. 178, 259.
70. Magnuson BA, Carr I, Bird RP. (1993) Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res. 53, 4499.
71. Magnuson BA, Shirtliff N, Bird RP. (1994) Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis 15, 1459.
72. Marra G, Boland CR. (1995) Hereditary nonpolyposis colorectal cancer. The syndrome, the genes, and historical perspective. J. Natl. Cancer Inst. 87, 1114.
73. Maskens AP, Deschner EE. (1977) Tritiated thymidine incorporation into epithelial cells of normal-appearing colorectal mucosa of cancer patients. J. Natl. Cancer Inst. 58, 1221.
74. McLellan EA, Bird RP. (1988a) Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res. 48, 6183.
75. McLellan EA, Bird RP. (1988b) Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res. 48, 6187.
76. McLellan EA, Bird RP (1991) Effect of disulfiram on 1,2-dimethylhydrazine-and axoxymethane-induced aberrant crypt foci. Carcinogenesis 12, 969.
77. McLellan EA, Medline A, Bird RP. (1991a) Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res. 51, 5270.
78. McLellan EA, Medline A, Bird RP. (1991b) Dose response and proliferative characteristics of aberrant crypt foci, putative preneoplastic lesions in rat colon. Carcinogenesis 12, 2093.
79. Mikhailowski R, Shpitz B, Polak-Charcon S et al. (1998) Controlled release of TGF-β1 impedes rat colon carcinogenesis in vivo. Int. J. Cancer 78, 618.
80. Moen CJA, Van Der Valk MA, Bird RP, Hart AAM, Demant P. (1996) Different genetic susceptibility to aberrant crypts and colon adenomas in mice. Cancer Res. 56, 2382.
81. Morin PJ, Sparks AB, Korinek V et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787.
82. Morin PJ, Vogelstein B, Kinzler KW. (1996) Apoptosis and APC in colorectai tumorigenesis. Proc. Natl. Acad. Sci. USA 93, 7950.
83. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. (1994) The APC. gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 54, 3676.
84. Muto T, Bussey HJR, Morson BC. (1975) The evolution of cancer of the colon and rectum. Cancer 36, 2251.
85. Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ. (1996) The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell Biol. 134, 165.
86. Nicolaides NC, Papadopoulos N, Liu B et al. (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371, 75 .
87. Nishisho I, Nakamura Y, Miyoshi Y et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665.
88. Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR. (1997) Phenotypic and genotypie characteristics of aberrant crypt foci in human colorectal mucosa. Hum. Pathol. 28, 1396.
89. Otoki K, Konishi M, Sugiyama K et al. (1998) Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue. Cancer 83, 896.
90. Otori K, Sugiyama K, Hasebe T, Fukushima S, Esumi H. (1995) Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 55, 4743.
91. Papadopoulos N, Nicolaides NC, Wei Y-F et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625.
92. Papanikolaou A, Wang QS. Delker DA, Rosenberg DW. (1998) Azoxymethane-induced colon tumor and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett. 130, 29.
93. Park H-S, Goodlad RA, Wright NA. (1997) The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazinc-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res. 57, 4507.
94. Paulsen JE, Steffensen I-L, Namork E, Alexander J. (1994) Scanning electron microscopy of aberrant crypt foci in rat colon. Carcinogenesis 15, 2371.
95. Payne CM, Bernstein H, Bernstein C, Garewai. H, (1995) Role of apoptosis in biology and pathology. resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol. 19, 221.
96. Piazza GA, Kulchak Rahm AL, Krutzch M et al. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55, 3110.
97. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW. (1996) Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am. J. Pathol. 149, 381.
98. Ponder BAJ, Schmidt GH, Wilkinson MM, Wood MJ, Monk M, Reid A. (1985) Derivation of mouse intestinal crypts from single progenitor cells. Nature 313, 689.
99. Ponz De Leon M, Roncucci L, Di Donato P et al. (1988) Pattern of epithelial cell proliferation on colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res. 48, 4121.
100. Potten CS. (1977) Extreme sensitivity of some intestinal crypt cells to X and γ irradiation. Nature 269, 518.
101. Potten CS. (1992) The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Review 11, 179.
102. Potten CS, Kellett M, Roberts SA, Rew DA, Wilson GD. (1992a) Measurement of in vitro proliferation in human colorectal mucosa using bromodeoxyuridine. Gut 33, 71.
103. Potten CS, Li QY, O'Conner PJ, Winton DJ. (1992b) A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens on the murine large bowel. Carcinogenesis 13, 2305.
104. Powell SM, Zuz N, Beazer-Barclay Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359, 235.
105. Prehn RT. (1994) Cancers beget mutations versus mutations beget cancers. Cancer Res. 54, 52965300.
106. Premoselli F, Sesca E, Binasco V, Caderni G, Tessitore L. (1998) Fasting/re-feeding before initiation enhances the growth of aberrant crypt foci induced by azoxymethane in rat colon and rectum. Int. J. Cancer 77, 286.
107. Pretlow TP, Barrow BJ, Ashton WS et al. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 51, 1564.
108. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. (1993) K-ras mutations in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 85, 2004.
109. Pretlow TP, Cheyer C, O'Riordan MA. (1994a) Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferate activity. Int. J. Cancer 56, 599.
110. Pretlow TP, O'Riordan MA, Kolman MF, Jurcisek JA. (1990) Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity. Am. J. Pathol. 136, 13.
111. Pretlow TP, Roukhadze EV, O'Riordan MA, Chan JC, Amini SB, Stellato TA. (1994b) Carcinoembryonie antigen in human colonie aberrant crypt foci. Gastroenterology 107, 1719.
112. Rao CV, Newmark HL, Reddy BS (1998) Chemopreventive effect of squalene on colon cancer. Carcinogenesis 19, 287.
113. Reitmar AH, Cai J-C, Bjerknes M et al. (1996) MSH. 2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56, 2922.
114. Riddell RH, Goldman H, Ransohoff DF et al. (1983) Dysplasia in inflammatory bowel disease. Standardized classification with provisional clinical applications. Hum. Pathol. 14, 931.
115. Risio M, Arrigoni A, Pennazio M, Agostinucci A, Spandre M, Rossini TP. (1995) Mucosal cell proliferation in patients with hyperplastic colorectal polyps. Scand. J. Gastroenterol. 30, 344.
116. Risio M, Lipkin M, Newmark H et al. (1996) Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res. 56, 4910.
117. Roncucci L, Medline A, Bruce WR. (1991b) Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol. Biomarkers Prev. 1, 57.
118. Roncucci L, Modica S, Pedroni M et al. (1998) Aberrant crypt foci in patients with colorectal cancer. Br. J. Cancer 77, 2343.
119. Roncucci L, Pedroni M, Fante R, Di Gregorio C, Ponz De Leon M. (1993) Cell kinetic evaluation of human colonic aberrant crypts. Cancer Res. 53, 3726.
120. Roncucci L, Ponz De Leon M, Scalmati A et al. (1988) The influence of age on colonic epithelial cell proliferation. Cancer 62, 2372.
121. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. (1991a) Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol. 22, 287.
122. Rubinfeld B, Souza B, Albert I et al. (1993) Association of the APC gene product with β-catenin. Science 262, 1731.
123. Sandforth F, Heimpel S, Balzer T, Gutschmidt S, Riecken O. (1988) Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine-induced colonic carcinogenesis. Eur J. Clin. Invest 18, 655.
124. Scalmati A, Roncucci L, Ghidini G, Biasco G, Ponz De Leon M. (1990) Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res. 50, 7937.
125. Senda T, Miyashiro I, Matsumine A et al. (1996) The tumor suppressor protein APC colocalizes with beta-catenin in the colon epithelial cells. Biochem. Biophys. Res. Commun. 223, 329.
126. Shamsuddin AKM, Weiss L, Phelps PC, Trump BF. (1981) Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon. J. Natl. Cancer Inst. 66, 413.
127. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonette RP, Green DR. (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257, 212.
128. Shivapurkar N, Huang L, Ruggeri B et al. (1997) K. -ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett. 115, 39.
129. Shivapurkar N, Tang Z, Ferreire A, Nasim S, Garett C, Alabaster O. (1994) Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet. Carcinogenesis 15, 775.
130. Shpitz B, Bomstein Y, Mekori Y et al. (1997) Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am. J. Surg. 174, 425.
131. Shpitz B, Bomstein Y, Mekori Y et al. (1998) Aberrant crypt foci in human colons, distribution and histomorphologic characteristics. Hum. Pathol. 29, 469.
132. Shpitz B, Hay K, Medline A et al. (1996) Natural history of aberrant crypt foci. A surgical approach. Dis. Colon Rectum 39, 763.
133. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237.
134. Siu I-M, Pretlow TG, Amini SB, Pretlow TP. (1997) Identification of dysplasia in human colonic aberrant crypt foci. Am. J. Pathol. 150, 1805.
135. Siu I-M, Robinson DR, Schwartz S et al. (1999) The identification of monoclonality in human aberrant crypt foci. Cancer Res. 59, 63.
136. Smith KJ, Jihnson KA, Bryan TM et al. (1993) The APC gene product in normal and tumor cells. Proc. Natl. Acatl. Sci. USA 90, 2846.
137. Smith AJ, Stern HS, Penner M et al. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colon. Cancer Res. 54, 5527.
138. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130.
139. Stadler J, Stern HS, Yeung KAS et al. (1988) Effect of high fat consumption on cell proliferation activity of colorectal mucosa, on soluble faecal bile acids. Gut 29, 1326.
140. Stamp D, Zhang XM, Medlini A, Bruce WR, Archer MC. (1993) Sucrose enhancement of the early steps of colon carcinogenesis in mice. Carcinogenesis 14, 777.
141. Stopera SA, Bird RP. (1992) Expression of ras oncogcne mRNA and protein in aberrant crypt foci. Carcinogenesis 13, 1863.
142. Stopera SA, Bird RP. (1993a) Effect of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci, differential expression of c-myc and c-fos mRNA and protein. Int. J. Cancer 53, 798.
143. Stopera SA, Bird RP. (1993b) Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci. Cytobios 73, 73.
144. Stopera SA, Davie JR, Bird RP. (1992a) Colonic aberrant crypt foci are associated with increased expression of c-fos. the possible role of modified c-fos expression in preneoplastic lesions in colon cancer. Carcinogenesis 13, 573.
145. Stopera SA, Murphy LC, Bird RP. (1992b) Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats. Earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis 13, 208.
146. Strãter J, Koretz K, Günthert AR, Mõller P. (1995) In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut 37, 819.
147. Su LK, Vogelstein B, Kinzler KW. (1993) Association of the APC tumor suppressor proteins with catenins. Science 262, 1734.
148. Takahashi M, Minamoto T, Yamashita N, Yazawa K, Sugimura T, Esumi H. (1993) Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt loci in rat colon by docosahexanoic acid. Cancer Res. 53, 2786.
149. Takayama T, Katsuki S, Takahashi Y et al. (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Mal. 339, 1177.
150. Terpstra OT, Vanblankenstein M, Dees J, Eilers GAM. (1987) Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 92, 704.
151. Thurnherr N, Deschner EE, Stonehill EN, Lipkin M. (1973) Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res. 33, 940.
152. Tochino N, Hayashi R, Luew C, Bailey G, Dashwood R. (1995) Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat. Mol. Carcinog. 12, 187.
153. Tudek G, Bird RP, Bruce WR. (1989) Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res. 49, 1236.
154. Tutton PJM, Barkla DH. (1987) Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells. Anticancer Res. 7, 1.
155. Tutton PJM, Barkla DH. (1988) Steroid hormones as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells. Anticancer Res. 8, 451.
156. Vaccina F, Scorcioni F, Pedroni M et al. (1998) Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa. Anticancer Res. 18, 3451.
157. Vivona AA, Shpitz B, Medline A et al. (1993) K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 14, 1777.
158. Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumour development. N. Engl. J. Med. 319, 525.
159. Wielenga VJ, Smits R, Korinek V et al. (1999) Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol. 154, 515.
160. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. (1995) Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 108, 434.
161. Yamashita N, Minamoto T, Onda M, Esumi H. (1994) Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn. J. Cancer Res. 85, 692.
162. Yang CM, Kendall CW, Stamp D, Medline A, Archer MC, Bruce WR. (1998) Thermally oxidized dietary-fat and colon carcinogenesis in rodents. Nutr. Cancer 30, 69.
163. Yokota T, Sugano K, Kondo H et al. (1997) Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest. Endoscopy 46, 61.
164. Zaidi NH, Pretlow TP, O'Riordan MA, Dumenco LL, Allay E, Gerson SL. (1995) Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis 16, 451.
165. Zhang XM, Stamp D, Minkin S et al. (1992) Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J. Natl. Cancer Inst. 84, 1026.